Brief: Adamis Pharmaceuticals Reports First Quarter 2023 Financial Results And Provides Corporate Update
15/05/2023 22:47
Adamis Pharmaceuticals Corp ADMP.O :
* ADAMIS PHARMACEUTICALS REPORTS FIRST QUARTER 2023
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* ADAMIS PHARMACEUTICALS CORP - CASH AND CASH EQUIVALENTS AS
OF
MARCH 31, 2023, WERE APPROXIMATELY $3.1 MILLION
* ADAMIS PHARMACEUTICALS CORP - QTRLY LOSS PER SHARE $0.06
Source text for Eikon: ID:nGNX4ClW7L
Further company coverage: ADMP.O
Recent news on DMK Pharmaceuticals
See all newsBrief: Dmk Pharmaceuticals Corp Says Ebrahim Versi Resigned As Chairman
Brief: ZMI Pharma Finalized Acquisition Of All Strategic Assets Necessary To Manufacture Zimhi From Dmk Pharma
Brief: DMK Pharmaceuticals Files For Chapter 11 Bankruptcy In The U.S. - Court Filing
Brief: Dmk Pharmaceuticals Regains Full Rights To Commercialize Zimhi
Brief: DMK Pharmaceuticals Regains Full Rights From US Worldmeds For Symjepi And Provides Corporate Update